VEGF Antibodies

Santa Cruz Biotechnology features a diverse variety of VEGF Antibodies for understanding vascular endothelial growth factor (VEGF) signaling pathways. VEGF Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VEGF plays a critical role in angiogenesis, the process of new blood vessel formation, which is essential for normal development and wound healing. VEGF signaling pathways are involved in various pathological conditions, including cancer, where they promote tumor growth by enhancing blood supply. Understanding VEGF function is crucial for developing targeted therapies in oncology and other diseases characterized by abnormal blood vessel growth. Researchers can investigate VEGF expression patterns in different tissue types and cellular environments. Advanced visualization techniques enable detailed analysis of VEGF localization and distribution within cellular structures. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), allowing for versatile experimental design. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of VEGF's role in health and disease.